Samsung Biologics

Related Companies

• Rentschler Biopharma SE
• 3P innovation

Related Content

GreenLight and Samsung complete first commercial-scale engineering run for mRNA COVID-19 vaccine

Navigating the maelstrom of M&A activity: what do CDMOs do next?

Samsung Biologics completes acquisition of Samsung Bioepis

Samsung Biologics acquires full ownership of Biogen joint venture

Samsung Biologics to manufacture AstraZeneca COVID therapy

GreenLight Biosciences and Samsung Biologics announce RNA collaboration

Driving biotherapeutic development with advanced molecule characterisation

Samsung Biologics to provide CDMO service for Enzolytics mAb therapies

Samsung Biologics to join Frontier 1.5D climate initiative

Samsung Biologics to provide end-to-end CDMO service for Kineta

Samsung Biologics to support Kahr Medical immunotherapy

Moderna and Samsung Biologics announce manufacturing agreement

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part III)

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part II)

The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part I)